As of 2025-05-18, the Relative Valuation of Atara Biotherapeutics Inc (ATRA) is (297.33) USD. This relative valuation is based on P/E multiples. With the latest stock price at 6.84 USD, the upside of Atara Biotherapeutics Inc based on Relative Valuation is -4447.0%.
The range of the Relative Valuation is (253.34) - (324.13) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.4x - 22.6x | 19.5x |
| Forward P/E multiples | 17.7x - 26.3x | 22.0x |
| Fair Price | (253.34) - (324.13) | (297.33) |
| Upside | -3803.8% - -4838.7% | -4447.0% |
| Date | P/E |
| 2025-05-16 | -0.48 |
| 2025-05-15 | -0.53 |
| 2025-05-14 | -0.46 |
| 2025-05-13 | -0.47 |
| 2025-05-12 | -0.45 |
| 2025-05-09 | -0.51 |
| 2025-05-08 | -0.52 |
| 2025-05-07 | -0.51 |
| 2025-05-06 | -0.54 |
| 2025-05-05 | -0.51 |
| 2025-05-02 | -0.55 |
| 2025-05-01 | -0.53 |
| 2025-04-30 | -0.56 |
| 2025-04-29 | -0.52 |
| 2025-04-28 | -0.52 |
| 2025-04-25 | -0.51 |
| 2025-04-24 | -0.53 |
| 2025-04-23 | -0.48 |
| 2025-04-22 | -0.47 |
| 2025-04-21 | -0.43 |
| 2025-04-17 | -0.43 |
| 2025-04-16 | -0.41 |
| 2025-04-15 | -0.42 |
| 2025-04-14 | -0.41 |
| 2025-04-11 | -0.39 |
| 2025-04-10 | -0.37 |
| 2025-04-09 | -0.41 |
| 2025-04-08 | -0.39 |
| 2025-04-07 | -0.40 |
| 2025-04-04 | -0.39 |
| 2025-04-03 | -0.41 |
| 2025-04-02 | -0.43 |
| 2025-04-01 | -0.42 |
| 2025-03-31 | -0.41 |
| 2025-03-28 | -0.46 |
| 2025-03-27 | -0.48 |
| 2025-03-26 | -0.46 |
| 2025-03-25 | -0.48 |
| 2025-03-24 | -0.48 |
| 2025-03-21 | -0.46 |
| 2025-03-20 | -0.47 |
| 2025-03-19 | -0.50 |
| 2025-03-18 | -0.49 |
| 2025-03-17 | -0.50 |
| 2025-03-14 | -0.51 |
| 2025-03-13 | -0.48 |
| 2025-03-12 | -0.48 |
| 2025-03-11 | -0.46 |
| 2025-03-10 | -0.43 |
| 2025-03-07 | -0.48 |